Papers/PMID:35224710
The Effect of Selenium Supplementation on Clinical Outcomes, Metabolic Profiles, and Pulsatility Index of the Uterine Artery in High-Risk Mothers in Terms of Preeclampsia Screening with Quadruple Test: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial : Selenium and preeclampsia.
Biological trace element research2023The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
selenium atom — decreases C-reactive protein concentration
Evidence strength: moderate.Findingreplicated ×2“Compared with the placebo, Se supplementation resulted in a significant elevation in TAC (β 82.88 mmol/L; 95% CI, 3.03, 162.73; P = 0.04), and GSH (β 71.35 µmol/L; 95% CI, 5.76, 136.94; P = 0.03), and a significant reduction in hs-CRP levels (β − 1.52 mg/L; 95% CI, − 2.91, − 0.14; P = 0.03).”
Quoted verbatim from The Effect of Selenium Supplementation on Clinical Outcomes, Metabolic Profiles, and Pulsatility Index of the Uterine Artery in High-Risk Mothers in Terms of Preeclampsia Screening with Quadruple Test: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial : Selenium and preeclampsia.. - Study
- RCT
- Duration
- 3 months
- Dose
- 200 ug/day selenium as selenium amino acid chelate with meals for 12 weeks
- Population
- Pregnant women aged 18-40 at high risk of pre-eclampsia on quadruple-test screening, supplemented from 16-18 weeks of gestation
The Effect of Selenium Supplementation on Clinical Outcomes, Metabolic Profiles, and Pulsatility Index of the Uterine Artery in High-Risk Mothers in Terms of Preeclampsia Screening with Quadruple Test: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial : Selenium and preeclampsia.2023PMID:3522471010.1007/s12011-022-03178-7Permalink